NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT02595905 2025-05-16Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesNational Cancer Institute (NCI)Phase 2 Completed344 enrolled
NCT01281696 2013-10-16Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisNational Taiwan University HospitalPhase 2 Completed40 enrolled
NCT00010023 2011-04-05Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsNYU Langone HealthPhase 1 Completed